These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7002233)

  • 21. "Aspirinated" platelets are hemostatic.
    Benjamin SP; Hoffman GC
    N Engl J Med; 1972 Apr; 286(14):784. PubMed ID: 5025790
    [No Abstract]   [Full Text] [Related]  

  • 22. The combined effects of N-3 fatty acids and aspirin on hemostatic parameters in man.
    Harris WS; Silveira S; Dujovne CA
    Thromb Res; 1990 Feb; 57(4):517-26. PubMed ID: 2109371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of aspirin on the size of the hemostatic plug.
    Kelton JG; Carter CJ
    Thromb Res; 1983 Nov; 32(3):267-73. PubMed ID: 6362058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of blood loss by infusion of human platelets in a rabbit kidney injury model.
    Krishnamurti C; Maglasang P; Rothwell SW
    Transfusion; 1999 Sep; 39(9):967-74. PubMed ID: 10533823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
    Preston FE; Whipps S; Jackson CA; French AJ; Wyld PJ; Stoddard CJ
    N Engl J Med; 1981 Jan; 304(2):76-9. PubMed ID: 7003384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical application of a new in vitro bleeding time device on surgical patients.
    Tsujinaka T; Itoh T; Uemura Y; Sakon M; Kambayashi J; Mori T
    Jpn J Surg; 1988 Jul; 18(4):430-7. PubMed ID: 2845175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemiluminescence response of human platelets.
    Mills EL; Gerrard JM; Filipovich D; White JD; Quie PG
    J Clin Invest; 1978 Mar; 61(3):807-14. PubMed ID: 641157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The thrombocytopenic rabbit bleeding time model to evaluate the in vivo hemostatic efficacy of platelets and platelet substitutes.
    Blajchman MA; Lee DH
    Transfus Med Rev; 1997 Apr; 11(2):95-105. PubMed ID: 9140169
    [No Abstract]   [Full Text] [Related]  

  • 29. Vascular thromboxane formation in hemostasis mechanism: correlation between bleeding time and vascular TXB2 in a patient with congenital platelet cyclo-oxygenase deficiency.
    Fuse I; Ootsuka T; Hattori A; Mito M; Shibata A
    Int J Hematol; 1996 Jun; 63(4):317-24. PubMed ID: 8762815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ASP6537, a novel highly selective cyclooxygenase-1 inhibitor, exerts potent antithrombotic effect without "aspirin dilemma".
    Sakata C; Kawasaki T; Kato Y; Abe M; Suzuki K; Ohmiya M; Funatsu T; Morita Y; Okada M
    Thromb Res; 2013 Jul; 132(1):56-62. PubMed ID: 23522855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increase in circulating megakaryocyte growth-promoting activity (Meg-GPA) following sublethal irradiation is not related to decreased platelets.
    Miura M; Jackson CW; Steward SA
    Exp Hematol; 1988 Feb; 16(2):139-44. PubMed ID: 3338510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet adhesion and mural platelet thrombus formation on aortic subendothelium of rats, rabbits, and guinea pigs correlate negatively with the vascular PGI2 production.
    Tschopp TB; Baumgartner HR
    J Lab Clin Med; 1981 Sep; 98(3):402-11. PubMed ID: 7021720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity of rabbit platelet and aortic cyclooxygenase to inhibition by aspirin.
    McDonald JW; de Kergommeaux BD; Ali M; Hayward CP
    Prostaglandins Leukot Med; 1983 Nov; 12(3):235-44. PubMed ID: 6419233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salicylate reverses in vitro aspirin inhibition of rat platelet and vascular prostaglandin generation.
    Merino J; Livio M; Rajtar G; de Gaetano G
    Biochem Pharmacol; 1980 Apr; 29(8):1093-6. PubMed ID: 6770871
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of acetylsalicylic acid and dietary intervention on primary hemostasis.
    Thorngren M; Gustafson A
    Am J Med; 1983 Jun; 74(6A):66-71. PubMed ID: 6344628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible significance of small numbers of functional platelets in a population of aspirin-treated platelets in vitro and in vivo.
    Cerskus AL; Ali M; Davies BJ; McDonald JW
    Thromb Res; 1980 May 1-15; 18(3-4):389-97. PubMed ID: 7414538
    [No Abstract]   [Full Text] [Related]  

  • 37. Dipyridamole and aspirin in relation to platelet aggregation and vessel wall prostaglandin generation.
    Mehta J; Mehta P
    J Cardiovasc Pharmacol; 1982; 4(4):688-93. PubMed ID: 6181345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex difference in the effect of aspirin on rat platelet aggregation and arachidonic acid metabolism.
    Morikawa M; Kojima T; Inoue M; Tsuboi M
    Jpn J Pharmacol; 1985 Apr; 37(4):317-23. PubMed ID: 3925205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of dilazep on human platelets and rat vascular tissue: in vitro studies on platelet aggregation, and arachidonic acid oxidation.
    Colli S; Maderna P; Morazzoni G; Speroni C; Tremoli E
    Pharmacol Res Commun; 1983 Jun; 15(6):593-602. PubMed ID: 6412253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostacyclin-thromboxane interactions in the platelet-perfused in vitro heart.
    Schrör K; Köhler P; Müller M; Peskar BA; Rösen P
    Am J Physiol; 1981 Jul; 241(1):H18-25. PubMed ID: 6264810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.